Xconomy: Agenda: What's Hot in Boston Biotech 2017


	5.11.2017	AGENDA
		.
	12:30 – 1:30	Registration & Networking
	1:30 – 1:40	Welcome & Opening Remarks Bob Buderi, Founder & CEO, Xconomy Paul McKenzie, EVP for Pharmaceutical Operations and Technology, Biogen
	1:40 – 2:10	Standing Up for Immigration and Diversity in Biotech Tony Coles, Chairman & CEO, Yumanity Therapeutics Susan Windham-Bannister, President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries Teresa Lavoie, Partner, Fish & Richardson (moderator)
	2:10 – 2:35	The Life Sciences in 2017 and Beyond: An Interactive Chat Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis Bob Buderi, Founder & CEO, Xconomy
	2:35 – 3:05	Battling the Opioid Crisis Richard Pops, Chairman & CEO, Alkermes Peter Koutoujian, Sheriff of Middlesex County, former member, Massachusetts House of Representatives
	3:05 – 3:35	Patient-Centric Drug Development Ed Kaye, President & CEO, Sarepta Therapeutics Peter Saltonstall, President & CEO, National Organization for Rare Disorders Abbie Celniker, Partner, Third Rock Ventures (moderator)
	3:35 – 4:05	Break
	4:05 – 4:25	Pioneering Life Science Ventures Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering
	4:25 – 5:00	Translating Science and Company Building: A Chat With Two Serial Entrepreneurs Michael Gilman, CEO & Chairman, Arrakis Therapeutics Katrine Bosley, CEO, Editas Medicine
	5:00 – 5:30	Cancer Therapies of the Future Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute David Schenkein, CEO, Agios Pharmaceuticals
	5:30 – 6:30	Networking Reception

*Schedule is subject to change.

Join us on May 11, register now.